Toggle Side Panel

Maternal RSV vaccination cuts infant hospitalisation

max
MariaPCC 5 May 2026

An UK Health Security Agency study highlights the efficacy of the maternal respiratory syncytial virus (RSV) vaccination in protecting newborn babies. The study shows that the RSV vaccine reduces the risk of hospitalisation in newborn infants by over 80 per cent when given at least two weeks before birth. Maternal RSV vaccine uptake in England continues to climb, reaching 55 per cent during the study period and the latest data showing uptake rising to 64.1 per cent for women who gave birth in November 2025. Materials are available to help communicate the benefits of the maternal vaccine programme, including the RSV vaccine, on the Campaign Resource Centre.

Categories: News

Report

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .
Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Weekly Newsletter

Daily news updates

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.